# A Study of Flibanserin in Breast Cancer Survivors on Tamoxifen or Aromatase Inhibitors

> **NCT03707340** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 43 (actual)

## Conditions studied

- Breast Cancer
- Hyposexual Desire Disorder

## Interventions

- **DRUG:** Flibanserin Pill

## Key facts

- **NCT ID:** NCT03707340
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-09-14
- **Primary completion:** 2026-10-14
- **Final completion:** 2026-10-14
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2025-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03707340

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03707340, "A Study of Flibanserin in Breast Cancer Survivors on Tamoxifen or Aromatase Inhibitors". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03707340. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*